客戶采用我司鏈霉親和素磁珠在SCI期刊《Analytical chemistry》發表論文
Luyao Shen, Keke Jia, Tao Bing*, Zhibao Zhang, Xiaoxiao Zhen, Xiangjun Liu, Nan Zhang, and Dihua Shangguan*. Detection of Circulating Tumor-Related Materials by Aptamer Capturing and Endogenous Enzyme-Signal Amplification, Anal. Chem. 2020, 92, 7, 5370–5378 (鏈霉親和素磁珠PuriMag G-Strep用于偶聯biotin修飾適配體)
原文請參考 https://pubs.acs.org/doi/abs/10.1021/acs.analchem.0c00051
Abstract
Circulating tumor-related materials (CTRMs) shed from original or metastatic tumors, carry a lot of tumor information and are considered as important markers for cancer diagnosis and metastasis prognosis. Herein, we report a colorimetric detection strategy for CTRMs based on aptamer-based magnetic isolation and endogenous alkaline phosphatase (AP)-signal amplification. This strategy exhibited high sensitivity and selectivity toward the CTRMs that express AP heterodimers (the target of aptamer, a potential tumor marker). For clinical samples, this CTRM assay significantly discriminated colorectal cancer patients (n = 50) from healthy individuals (n = 39, p < 0.0001). The receiver operating characteristic (ROC) analysis indicated the sensitivity and specificity reached 92% and 82%, respectively, at the optimal cutoff point, the area under the curve of ROC reached 0.93, suggesting great potential for colorectal cancer diagnosis and therapeutic monitoring. Compared with CTC assays, this strategy is simple and has the potential for point-of-care testing.
從原始或轉移性腫瘤中脫落的循環腫瘤相關材料（CTRM），攜帶大量腫瘤信息，被認為是癌癥診斷和轉移預后的重要標志。在這里，我們報告基于適體的磁隔離和內源性堿性磷酸酶（AP）信號放大基于CTRMs的比色檢測策略。該策略對表達AP異二聚體（適體的靶標，一種潛在的腫瘤標志物）的CTRM表現出高敏感性和選擇性。對于臨床樣品，該CTRM分析顯著區分了大腸癌患者（n = 50）和健康個體（n = 39，p <0.0001）。接受者操作特征（ROC）分析表明，在最佳截止點，ROC曲線下面積達到0.93，靈敏度和特異性分別達到92％和82％，這為大腸癌的診斷和治療監測提供了巨大的潛力。與CTC分析相比，此策略簡單易行，具有即時檢驗的潛力。
購買鏈霉親和素磁珠請參考
- 上一篇：IVD 診斷技術的優缺點綜合比較 2021/3/9
- 下一篇：抗體純化方法簡介（附示意圖） 2021/2/28